Ana Ávila Bernabéu

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution

Tomás Cortadellas, Octavi Córdoba, A. Gascón et al. · European Journal of Surgical Oncology · 2015 · 23 citations

Nursing, Geriatric Oncology, Surgical Oncology +10

Donor-Specific HLA Antibodies: Risk Factors and Outcomes After Kidney Transplantation

J. Kanter Berga, L.M. Pallardó Mateu, Sandra Beltrán Catalán et al. · Transplantation Proceedings · 2011 · 18 citations

Transplant Rejection, Hla, Transplantation +12

Vitamin D Deficiency in a Renal Transplant Population: Safe Repletion With Moderate Doses of Calcidiol

J. Kanter Berga, J. Crespo Albiach, Sandra Beltrán Catalán et al. · Transplantation Proceedings · 2010 · 18 citations

Urology, Kidney Transplant, Medicine +7